Mercedes Robledo

Mercedes Robledo at CNIO is a leading expert in hereditary pheochromocytoma and paraganglioma syndromes, contributing foundational work on the clinical significance of SDHB mutations and their association with malignant behavior. Her research has characterized the metabolic consequences of succinate dehydrogenase deficiency and its role in tumor development. She has established comprehensive registries for hereditary pheochromocytoma patients and contributed to understanding genotype-phenotype correlations. Her work on germline testing algorithms and cascade screening for at-risk family members has improved hereditary pheochromocytoma management.